Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses - PubMed (original) (raw)
Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses
R Ralston et al. J Virol. 1993 Nov.
Abstract
We constructed recombinant vaccinia virus vectors for expression of the structural region of hepatitis C virus (HCV). Infection of mammalian cells with a vector (vv/HCV1-906) encoding C-E1-E2-NS2 generated major protein species of 22 kDa (C), 33 to 35 kDa (E1), and 70 to 72 kDa (E2), as observed previously with other mammalian expression systems. The bulk of the E1 and E2 expressed by vv/HCV1-906 was found integrated into endoplasmic reticulum membranes as core-glycosylated species, suggesting that these E1 and E2 species represent intracellular forms of the HCV envelope proteins. HCV E1 and E2 formed E1-E2 complexes which were precipitated by either anti-E1 or anti-E2 serum and which sedimented at approximately 15 S on glycerol density gradients. No evidence of intermolecular disulfide bonding between E1 and E2 was detected. E1 and E2 were copurified to approximately 90% purity by mild detergent extraction followed by chromatography on Galanthus nivalus lectin-agarose and DEAE-Fractogel. Immunization of chimpanzees with purified E1-E2 generated high titers of anti-E1 and anti-E2 antibodies. Further studies, to be reported separately, demonstrated that purified E1-E2 complexes were recognized at high frequency by HCV+ human sera (D. Y. Chien, Q.-L. Choo, R. Ralston, R. Spaete, M. Tong, M. Houghton, and G. Kuo, Lancet, in press) and generated protective immunity in chimpanzees (Q.-L. Choo, G. Kuo, R. Ralston, A. Weiner, D. Chien, G. Van Nest, J. Han, K. Berger, K. Thudium, J. Kansopon, J. McFarland, A. Tabrizi, K. Ching, B. Mass, L. B. Cummins, E. Muchmore, and M. Houghton, submitted for publication), suggesting that these purified HCV envelope proteins display native HCV epitopes.
Similar articles
- Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.
Logan M, Law J, Wong JAJ, Hockman D, Landi A, Chen C, Crawford K, Kundu J, Baldwin L, Johnson J, Dahiya A, LaChance G, Marcotrigiano J, Law M, Foung S, Tyrrell L, Houghton M. Logan M, et al. J Virol. 2016 Dec 16;91(1):e01552-16. doi: 10.1128/JVI.01552-16. Print 2017 Jan 1. J Virol. 2016. PMID: 27795422 Free PMC article. - Characterization of truncated forms of hepatitis C virus glycoproteins.
Michalak JP, Wychowski C, Choukhi A, Meunier JC, Ung S, Rice CM, Dubuisson J. Michalak JP, et al. J Gen Virol. 1997 Sep;78 ( Pt 9):2299-306. doi: 10.1099/0022-1317-78-9-2299. J Gen Virol. 1997. PMID: 9292018 - Expression and identification of hepatitis C virus polyprotein cleavage products.
Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM. Grakoui A, et al. J Virol. 1993 Mar;67(3):1385-95. doi: 10.1128/JVI.67.3.1385-1395.1993. J Virol. 1993. PMID: 7679746 Free PMC article. - Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets.
Freedman H, Logan MR, Law JL, Houghton M. Freedman H, et al. ACS Infect Dis. 2016 Nov 11;2(11):749-762. doi: 10.1021/acsinfecdis.6b00110. Epub 2016 Aug 16. ACS Infect Dis. 2016. PMID: 27933781 Review. - Hepatitis C virus envelope glycoproteins and potential for vaccine development.
Beyene A, Basu A, Meyer K, Ray R. Beyene A, et al. Vox Sang. 2002 Aug;83 Suppl 1:27-32. doi: 10.1111/j.1423-0410.2002.tb05262.x. Vox Sang. 2002. PMID: 12617098 Review.
Cited by
- Malignancy and viral infections in Sub-Saharan Africa: A review.
Diakite M, Shaw-Saliba K, Lau CY. Diakite M, et al. Front Virol. 2023;3:1103737. doi: 10.3389/fviro.2023.1103737. Epub 2023 Mar 6. Front Virol. 2023. PMID: 37476029 Free PMC article. - Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review.
Elbahrawy A, Atalla H, Alboraie M, Alwassief A, Madian A, El Fayoumie M, Tabll AA, Aly HH. Elbahrawy A, et al. Viruses. 2023 Jan 12;15(1):214. doi: 10.3390/v15010214. Viruses. 2023. PMID: 36680254 Free PMC article. Review. - Structural and Biophysical Characterization of the HCV E1E2 Heterodimer for Vaccine Development.
Toth EA, Chagas A, Pierce BG, Fuerst TR. Toth EA, et al. Viruses. 2021 May 29;13(6):1027. doi: 10.3390/v13061027. Viruses. 2021. PMID: 34072451 Free PMC article. Review. - Evaluation of a Series of Lipidated Tucaresol Adjuvants in a Hepatitis C Virus Vaccine Model.
Belz TF, Olson ME, Giang E, Law M, Janda KD. Belz TF, et al. ACS Med Chem Lett. 2020 Oct 29;11(12):2428-2432. doi: 10.1021/acsmedchemlett.0c00413. eCollection 2020 Dec 10. ACS Med Chem Lett. 2020. PMID: 33335664 Free PMC article. - Antibody Responses in Hepatitis C Infection.
Law M. Law M. Cold Spring Harb Perspect Med. 2021 Mar 1;11(3):a036962. doi: 10.1101/cshperspect.a036962. Cold Spring Harb Perspect Med. 2021. PMID: 32341067 Free PMC article. Review.
References
- Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10011-5 - PubMed
- J Immunol. 1992 Nov 15;149(10):3339-44 - PubMed
- J Virol. 1993 Mar;67(3):1385-95 - PubMed
- Nature. 1970 Aug 15;227(5259):680-5 - PubMed
- Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources